2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on IO in Advanced NSCLC: Nivo/Ipi + 2 Cycles of Chemo vs. 4 Cycles of Chemo - Did OS Improve?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Shayma Kazmi
By 2020 ASCO Virtual Direct™ Highlights FEATURING Shayma Kazmi
97 views
September 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Lung
24:44
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on EGFR+ NSCLC: Adjuvant Gefitinib, Adjuvant Osimer…

Feat. S. Kazmi
09:21
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on IO in Advanced NSCLC: Nivo/Ipi + 2 Cycles of Che…

Feat. S. Kazmi
08:01
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HER2+ NSCLC: Did Trastuzumab Deruxtecan Demonstr…

Feat. S. Kazmi
08:01
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on SCLC: Can a Higher TRT-Dose Prolong Survival…

Feat. S. Patel
07:39
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Localized NSCLC: Does the Addition of Pembro…

Feat. S. Patel
06:39
2020 ASCO Virtual Direct™ Highlights

Adjuvant Therapy in Resectable NSCLC: What Does ADAURA Data Suggest …

Feat. S. Patel